Integer Holdings Corp is a leading provider of advanced medical devices and components, specializing in the design and manufacture of innovative solutions for the healthcare industry
The company focuses on developing products that support critical therapeutic and diagnostic applications, catering to a diverse range of medical markets including cardiovascular, orthopedics, and neuromodulation. Integer's expertise encompasses a variety of technologies, enabling it to deliver high-quality, reliable medical products that enhance patient outcomes and drive advancements in healthcare. Through strategic partnerships and a commitment to innovation, Integer Holdings Corp plays a vital role in improving lives and expanding the possibilities of medical technology.
PLANO, Texas, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSEITGR) today announced that it has priced an offering of $435 million aggregate principal amount of 2.125% convertible senior notes due 2028 (the “Convertible Notes”). The offering was upsized from the previously announced offering size of $375 million aggregate principal amount of Convertible Notes. The Company granted to the initial purchasers of the Convertible Notes an option to purchase up to an additional $65 million aggregate principal amount of the Convertible Notes for settlement within a 13-day period beginning on, and including, the first day on which the Convertible Notes are issued. The offering is expected to close on February 3, 2023, subject to customary closing conditions.
~ Preliminary fourth quarter 2022 sales increase of 18% to 19% versus 2021 ~~ Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call ~
PLANO, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSEITGR) today announced that it intends to offer, subject to market and other conditions, $375 million aggregate principal amount of its convertible senior notes due 2028 (the “Convertible Notes”).
SAN JOSE, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the appointments of several new directors following the closing of the Company’s rights offering as previously announced on November 29, 2022. Patient Square Capital became the Company’s majority owner upon closing of the rights offering and conversion of Patient Square’s senior secured convertible notes per its investment in June 2022.
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- Certain directors of Integer Holdings Corporation are under investigation over potential breaches of fiduciary duties.
